Navigation Links
ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting
Date:3/12/2009

PHILADELPHIA, March 12 /PRNewswire/ -- ERT, a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, announced today that it will be showcasing its portfolio of products and services on Booth #1253/1254 at the 21st Annual DIA Euromeeting, 23-25 March 2009 in Berlin, Germany. ERT is also inviting attendees to three speaking sessions, which will discuss the impact of technology and standards on drug delivery.

Following a successful company rebranding exercise, ERT has unveiled four new sub-brands of its industry-leading products and services, including ERT Cardiac Safety Solutions, ERT EDC Solutions, ERT ePRO Solutions, and ERT Clinical Research Consulting Group. ERT representatives will be on booth at the DIA Euromeeting to discuss the Company's latest innovations, as well as the latest advancements within the industry.

In addition, ERT will be taking part in three presentations at the Euromeeting under the conference track, The Impact of Technology and Standards on Drug Development: Now Better, Safer and Faster. The first talk, entitled "The Loose Ends in EDC and How to Address Them," will be held on 24 March between 4:00 pm - 5:30 pm. The second session - "A Look into the Future: What is on the Horizon After We Have Managed EDC Properly?" - will be held from 9:00 am to 10:30 am, on 25 March. The final session will also be held on 25 March between 2:00 pm - 3:30 pm entitled "CDISC end-to-end: To What Extent Do the CDISC Standards Achieve Information System Independence?"

DIA's 21st Annual Euromeeting attracts more than 3,000 professionals from over 50 countries. It brings together representatives from the biopharmaceutical industry, contract service organizations, academic research centers, regulatory agencies, health ministries, patients' organizations and trade associations. More than 240 exhibitors will be taking part at the DIA meeting, which will also feature more than 125 sessions and 21 preconference tutorials focusing on issues affecting global drug discovery and development.

ERT is a leading provider of technology and services to the biopharmaceutical and medical device industries around the world. The four key areas of ERT products and services are all enabled by the Company's innovative technology platform - EXPERT(TM). EXPERT(TM) is a robust, secure, and validated clinical-research workflow-processing system that powers centralized electronic data collection, data management, and information exchange.

For further information about ERT's clinical trial solutions please visit Booth #1253/1254 at DIA 21st Annual Euromeeting in Berlin. Alternatively, please email info@ert.com, call +1 866 538 2808 or visit www.ert.com.

About ERT

Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (www.ert.com) is a provider of technology and services to the biopharmaceutical and medical device industries on a global basis. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2009 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
2. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
3. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
4. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
5. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
6. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
7. CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line
8. Tasker Products to Showcase Tasker Blue at International Poultry Expo
9. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
10. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
11. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... and manufacturing company, today announced several positive developments that position the Company for ... a result of the transaction, Craig F. Kinghorn has been appointed Chairman of ...
(Date:5/25/2016)... ... May 25, 2016 , ... Lajollacooks4u has become a rising hotspot for specialized ... of its top attractions. Fortune 500 companies, such as Illumina, Hewlett-Packard, Qualcomm and ... intimate team-building experience. , Each event kicks off with an olive oil and salt-tasting ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle Plating ... options designed to address fractures of the distal tibia and fibula. This system ... Ankle Plating System 3 is composed of seven plate families that span the ...
(Date:5/25/2016)... ... 25, 2016 , ... The American Medical Informatics Association (AMIA) ... National Coordinator for Health IT (ONC) outlining a measurement approach to interoperability that ... when and where it was needed. The organization of health informatics professionals said ...
Breaking Biology Technology:
(Date:3/18/2016)... --> --> ... & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection ... border security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, ... defence & security companies in the border security ...
(Date:3/15/2016)... New York , March 15, 2016 ... new market report published by Transparency Market Research "Digital Door ... Trends and Forecast 2015 - 2023," the global digital door ... US$ 731.9 Mn in 2014 and is forecast to grow ... 2023. Growth of micro, small and medium enterprises (MSMEs) across ...
(Date:3/14/2016)... NXTD ) ("NXT-ID" or the "Company"), a company ... of a new series of commercials on Time Warner Cable ... .  The commercials will air on Bloomberg TV, Fox Business ... show. --> NXTD ) ("NXT-ID" or the "Company"), ... the airing of a new series of commercials on Time ...
Breaking Biology News(10 mins):